findmyKOL

Gerald Gacioch, MD

Basic profile

Rochester General Hospital

ORCIDNone on fileNPI↗
✓ Full record
RegionRochester, NY · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL type: RegionalLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Gerald Gacioch is a Cardiology physician affiliated with Rochester General Hospital. OpenAlex indexes 15 publications with 1,027 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
15publications

Distinct works indexed by OpenAlex.

1,027citations

Total citations across indexed works.

7h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

30 Hagen Dr
Suite 100
Rochester, NY 146252658

Telephone

585-338-2700

Provider last certified this registry record 28 Sept 2022.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    79.2%
    Beta blocker20%
    Metoprolol Succinate46%Metoprolol Tartrate25%Carvedilol20%Atenolol6%Labetalol Hcl3%
    Part D<11 patients
    Statin17.4%
    Atorvastatin Calcium62%Rosuvastatin Calcium32%Simvastatin4%Pravastatin Sodium3%
    Part D<11 patients

    + 13 more classes in this area

  • Blood & clotting

    17.5%
    Factor Xa inhibitor9.4%
    Eliquis88%Xarelto12%
    Part D<11 patients
    P2Y12 inhibitor7.2%
    Clopidogrel91%Brilinta9%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    3.3%
    SGLT2 inhibitor2.3%
    Jardiance52%Farxiga48%
    Part D<11 patients
    Potassium supplement1.1%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)83.4% facility · 16.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”